Veltex Corporation (VLXC)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -583.97 Thousand | -48.7 Thousand | -429.66 Thousand | -320.95 Thousand | -315.05 Thousand | -230.02 Thousand |
| Net Income | -1.06 Million | -3.88 Million | -3.23 Million | -2.82 Million | -862.87 Thousand | -545.28 Thousand |
| Depreciation & Amortization | 144.06 Thousand | 130.44 Thousand | 38.59 Thousand | - | - | - |
| Deferred income taxes | -964.28 Thousand | - | -2.5 Million | - | - | - |
| Stock-based compensation | 205 Thousand | 3.27 Million | 2.42 Million | - | - | - |
| Change in working capital | 120.02 Thousand | 870.12 Thousand | 345.01 Thousand | 60.48 Thousand | 2818.00 | 55.26 Thousand |
| Other non-cash items | 974.28 Thousand | -441.36 Thousand | 2.5 Million | 2.44 Million | 545 Thousand | 260 Thousand |
| Investing Cash Flow | -56.76 Thousand | -93.02 Thousand | -73.67 Thousand | - | - | - |
| Investments in PPE | -56.76 Thousand | -93.02 Thousand | -73.67 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 644 Thousand | 20 Thousand | 600 Thousand | 346.03 Thousand | 317.16 Thousand | 226.62 Thousand |
| Debt repayment | -514 Thousand | - | - | -206.03 Thousand | -5332.00 | -136.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 130 Thousand | 20 Thousand | 600 Thousand | 120 Thousand | 322.5 Thousand | 90 Thousand |
| Other Financing Activities | 130 Thousand | - | - | 20 Thousand | - | - |
| Accounts receivables | -575.11 Thousand | -9159.00 | -3981.00 | - | - | - |
| Accounts payables | 103.96 Thousand | 33.55 Thousand | 4900.00 | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 591.17 Thousand | 845.72 Thousand | 344.09 Thousand | 60.48 Thousand | 2818.00 | 55.26 Thousand |
| Cash at beginning of period | 2178.00 | 123.9 Thousand | 27.25 Thousand | 2169.00 | 54.00 | 3453.00 |
| Cash at end of period | 5441.00 | 2178.00 | 123.9 Thousand | 27.25 Thousand | 2169.00 | 54.00 |
| Capital Expenditure | -56.76 Thousand | -93.02 Thousand | -73.67 Thousand | - | - | - |
| Effect of forex changes on cash | -306.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 3263.00 | -121.72 Thousand | 96.65 Thousand | 25.08 Thousand | 2115.00 | -3399.00 |
| Free Cash Flow | -640.73 Thousand | -141.72 Thousand | -503.34 Thousand | -320.95 Thousand | -315.05 Thousand | -230.02 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.95 Thousand | -242.05 Thousand | -1.06 Million | 111.59 Thousand | -148.24 Thousand | -6869.00 |
| Depreciation & Amortization | 37.67 Thousand | 36.65 Thousand | 144.06 Thousand | 35.75 Thousand | 36.65 Thousand | 35.9 Thousand |
| Deferred income taxes | - | - | -964.28 Thousand | - | - | - |
| Stock-based compensation | - | 100 Thousand | 205 Thousand | - | - | - |
| Change in working capital | -203.7 Thousand | -170.77 Thousand | 120.02 Thousand | 508.07 Thousand | -164.19 Thousand | -16.55 Thousand |
| Other non-cash items | 295.75 Thousand | 419.49 Thousand | 974.28 Thousand | -508.43 Thousand | 271.93 Thousand | 376.14 Thousand |
| Investing Cash Flow | -7500.00 | -23.45 Thousand | -56.76 Thousand | -19.25 Thousand | -16.52 Thousand | -17.98 Thousand |
| Investments in PPE | -7500.00 | -23.45 Thousand | -56.76 Thousand | -19.25 Thousand | -16.52 Thousand | -17.98 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 60.46 Thousand | 432.44 Thousand | 644 Thousand | -190.84 Thousand | 292.98 Thousand | 221.99 Thousand |
| Debt repayment | -60.46 Thousand | -432.44 Thousand | -514 Thousand | -255.84 Thousand | -257.98 Thousand | -221.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 130 Thousand | 65 Thousand | 35 Thousand | - |
| Other Financing Activities | - | - | - | - | - | 443.99 Thousand |
| Accounts receivables | -250.26 Thousand | -242.92 Thousand | -575.11 Thousand | 84.43 Thousand | -218.47 Thousand | -326.05 Thousand |
| Accounts payables | 29.85 Thousand | -3265.00 | 103.96 Thousand | 40.55 Thousand | 19.85 Thousand | 21.72 Thousand |
| Inventory | - | - | - | - | - | 272.77 Thousand |
| Other working capital | 16.7 Thousand | 75.41 Thousand | 591.17 Thousand | 383.08 Thousand | 34.42 Thousand | 15 Thousand |
| Cash at beginning of period | 138.25 Thousand | 5441.00 | 2178.00 | 15.08 Thousand | 14.4 Thousand | 19.91 Thousand |
| Cash at end of period | 51.13 Thousand | 138.25 Thousand | 5441.00 | 5441.00 | 15.08 Thousand | 14.4 Thousand |
| Capital Expenditure | -7500.00 | -23.45 Thousand | -56.76 Thousand | -19.25 Thousand | -16.52 Thousand | -17.98 Thousand |
| Effect of forex changes on cash | - | - | -306.00 | -1.00 | - | -221.99 Thousand |
| Net cash flow / Change in cash | -87.11 Thousand | 132.81 Thousand | 3263.00 | -9643.00 | 676.00 | -5504.00 |
| Free Cash Flow | -147.58 Thousand | -299.63 Thousand | -640.73 Thousand | 181.2 Thousand | -292.3 Thousand | -5504.00 |
MCLEODRUSS
MDRSF
688697
BIOL
1072
DOTZ3